VSIR and hepatocellular carcinoma: Previous studies showed that VISTA was expressed in 29.5% of hepatocellular carcinoma, 51.4% of HGSOC, 25.6% of pancreatic cancer cells in 100% of endometrial cancer, and 99% of lung cancer (3, 6, 8, 30).